ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #6,808Hybrid

Current Problems in Cancer

Acronym:ymcn
•
Abbreviation (ISO):CURR PROB CANCER
•
Identifier (ISSN):0147-0272(Print)/1535-6345(Online)
•
Publisher:Mosby Inc.
Clarivate IF (2026)
2.4↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Problems in Cancer

WoS Q3
12451.6120183.720193.2620203.1920212.3720222.620232.520242.320252.42026
Annual Impact Factor Metric
Current (2026):2.4
Scopus SJR & RankScopus Q2
0.808
#6,808

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
54

54 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
88articles/year
21.48% Gold OA•84.48% Original Research

Aims & Scope

Current Problems in Cancer seeks to promote and disseminate innovative, transformative, and impactful data on patient-oriented cancer research and clinical care. Specifically, the journal's scope is focused on reporting the results of well-designed cancer studies that influence/alter practice or identify new directions in clinical cancer research. These studies can include novel therapeutic approaches, new strategies for early diagnosis, cancer clinical trials, and supportive care, among others. Papers that focus solely on laboratory-based or basic science research are discouraged. The journal's format also allows, on occasion, for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering articles that present dynamic material that influences the oncology field.

Topics Covered (Recognized by AI)
Medicine99.8%Biology55.9%Internal medicine54.2%Genetics49.7%Cancer40.5%Pathology38.1%Oncology30.7%Surgery29.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q3
Rank214/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank202/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.4
Articles / Year42
Total Citations10
2025
IF2.3
Articles / Year52
Total Citations64
2024
IF2.5
Articles / Year74
Total Citations349
2023
IF2.6
Articles / Year68
Total Citations328
2022
IF2.367
Articles / Year61
Total Citations482

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,808Scopus Q2SCImago Profile
Scopus Coverage:1976-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.808

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.79

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,210 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations439
3-Year Documents162
Citable Documents154

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ2
Cancer ResearchQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Problems in Cancer (acronym: ymcn, abbr: CURR PROB CANCER, ISSN: 0147-0272) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mosby Inc. in United States since 1976. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.808 (Q2), an H-index of 54.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 88 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,210 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Mosby Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
1976
Indexing & Databases
SCIEScopusPubMed
Editorial Address
MOSBY-ELSEVIER, 360 PARK AVENUE SOUTH, NEW YORK, USA, NY, 10010-1710

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4e324966-8253-48db-9208-fe09347a3764
Database Updated: 2026-10-16